Scope

This site is an educational reference. Its content describes published research, mechanism of action, safety profiles as reported in the literature, and regulatory status. It does not constitute medical advice, treatment recommendation, or guidance for human use. Readers seeking medical advice should consult a qualified clinician.

UK regulatory position

Under the Human Medicines Regulations 2012, supply of unlicensed medicines for human consumption is restricted. None of the peptides discussed on this site is licensed as a medicine by the UK Medicines and Healthcare products Regulatory Agency (MHRA). Sale, supply, or importation of these compounds for human use is not permitted under that legislation.

None of the peptides discussed on this site is, at the time of writing, listed under the Misuse of Drugs Act 1971. They are therefore not controlled drugs in the conventional sense. This does not, however, make them legal for human use — only legal to possess as research chemicals.

Liability

Information on this site is provided as-is, without warranty of completeness or accuracy. The site authors accept no liability for any action taken on the basis of information presented here. Researchers using these compounds in laboratory work do so under their own professional and institutional responsibility.

External links

Links to external suppliers (PeptideBarn.co.uk, PeptideAuthority.co.uk) are provided as research-sourcing references. The site does not vouch for the quality, purity, or regulatory compliance of any specific commercial supplier. Researchers should perform their own due diligence — third-party purity testing, supplier credentialing, and documentation review — before placing any order.

Changes

The regulatory status of research peptides can change. While this site is kept reasonably current, readers should verify the current status of any specific compound with primary regulatory sources (MHRA, Home Office) before relying on the position stated here.